Clinical Study
CVL- 865: A study drug for people with drug-resistant Focal Onset Seizures
This study is open to participants who were in the previous seizure trial numbered CVL-865-SZ-001. This study will give these previous participants open-label treatment with the study drug for 57 weeks. The study drug is called CVL- 865.
For more information contact:
Laura Beeler
laura.beeler@hsc.utah.edu
801-585-9266
IRB#: IRB_00166301
| PI: Amir Arain
| Department: NEUROLOGY
| Approval Date: 2023-06-28 06:00:00
Study Categories: Neurological Studies
| Specialties: Neurology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes